Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
Bogdan Ionel Tamba, Gabriela Dumitrița Stanciu, Cristina Mariana Urîtu, et al.
Medicina (2020) Vol. 56, Iss. 1, pp. 24-24
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets
Seyed Alireza Salami, Federico Martinelli, Antonio Giovino, et al.
Molecules (2020) Vol. 25, Iss. 18, pp. 4036-4036
Open Access | Times Cited: 72
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
Leontina Elena Filipiuc, Daniela Carmen Ababei, Teodora Alexa‐Stratulat, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1823-1823
Open Access | Times Cited: 56
Cannabis Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain
Giuseppina Crescente, Giuseppe Minervini, Carmela Spagnuolo, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 106-106
Open Access | Times Cited: 49
The Skin and Natural Cannabinoids–Topical and Transdermal Applications
Silviu-Iulian Filipiuc, Anca-Narcisa Neagu, Cristina Mariana Urîtu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1049-1049
Open Access | Times Cited: 19
Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence
Kawthar Safi, Jan Sobieraj, Michał Błaszkiewicz, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 307-307
Open Access | Times Cited: 7
Data-enriched edible pharmaceuticals (DEEP) of medical cannabis by inkjet printing
Heidi Öblom, Claus Cornett, Johan Bøtker, et al.
International Journal of Pharmaceutics (2020) Vol. 589, pp. 119866-119866
Closed Access | Times Cited: 47
Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids
Dennis J. Sholler, Marilyn A. Huestis, Benjamin Amendolara, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173059-173059
Open Access | Times Cited: 39
The Future of Substance Abuse Now: Relationships among Adolescent Use of Vaping Devices, Marijuana, and Synthetic Cannabinoids
Hsiangyi Tai, Michael D. Swartz, David Marsden, et al.
Substance Use & Misuse (2021) Vol. 56, Iss. 2, pp. 192-204
Open Access | Times Cited: 30
Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation
Cindy H. J. Yu, H.P. Vasantha Rupasinghe
Research in Veterinary Science (2021) Vol. 140, pp. 38-46
Closed Access | Times Cited: 30
The Association Between Past 12-Month Synthetic Cannabinoid Polysubstance Use and Cannabis Use Disorder in a Nationally Representative US Sample
Weisiyu Qin, Dong‐Chul Seo, Shin Hyung Lee, et al.
International Journal of Mental Health and Addiction (2025)
Closed Access
Investigation of Cannabinoid Acid/Cyclodextrin Inclusion Complex for Improving Physicochemical and Biological Performance
Chulhun Park, Jieyu Zuo, Myung-Chul Gil, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2533-2533
Open Access | Times Cited: 8
Should oncologists trust cannabinoids?
Ioana Creangă-Murariu, Leontina Elena Filipiuc, Magdalena Cuciureanu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Cannabinoids as multifaceted compounds
Diana Persia, Francesca Mangiavacchi, Maria Carla Marcotullio, et al.
Phytochemistry (2023) Vol. 212, pp. 113718-113718
Open Access | Times Cited: 5
Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified Cannabis sativa L. in Rodents
Leontina Elena Filipiuc, Raluca Ştefănescu, Carmen Solcan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 694-694
Open Access | Times Cited: 5
Anesthesia and analgesia in laboratory rodents
Paulin Jirkof, Jennie Lofgren
Elsevier eBooks (2023), pp. 287-356
Closed Access | Times Cited: 5
Cannabis: Past, present, and future
Francisco Gomes Bonetto Schinko, Thiago de Mello Tavares, Mateus Fiuza Santos
Seven Editora eBooks (2024)
Open Access | Times Cited: 1
The potential neuroprotective effects of cannabinoids against paclitaxel-induced peripheral neuropathy: in vitro study on neurite outgrowth
Ioana Creangă-Murariu, Leontina Elena Filipiuc, Maria-Raluca Gogu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization
Astrid Coronado-Álvarez, Karen Romero-Cordero, Lorena Macías-Triana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 110, pp. 110301-110301
Closed Access | Times Cited: 9
Unique Approach of a Telemedicine System for CBD-Infused Foods
Nam-Soo Kim, Abhilash Aditya, Hyun-Jin Kang, et al.
Processes (2021) Vol. 9, Iss. 6, pp. 936-936
Open Access | Times Cited: 7
Cannabis, cannabinoids, and cannabis-based medicines: future research directions for analgesia
Ignacio Badiola, Amit Doshi, Samer Narouze
Regional Anesthesia & Pain Medicine (2022) Vol. 47, Iss. 7, pp. 437-444
Closed Access | Times Cited: 4
The Roles of Imaging Biomarkers in the Management of Chronic Neuropathic Pain
Cosmin Vasilica Pricope, Bogdan Ionel Tamba, Gabriela Dumitrița Stanciu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13038-13038
Open Access | Times Cited: 4
Medicinal Cannabis and Synthetic Cannabinoid Use
Simona Pichini, Alfredo Fabrizio Lo Faro, Francesco Paolo Busardò, et al.
Medicina (2020) Vol. 56, Iss. 9, pp. 453-453
Open Access | Times Cited: 4
The potential of cannabis in pain management
Chandan Chauhan, Montu, Mukul Singh, et al.
Elsevier eBooks (2024), pp. 205-231
Closed Access
The State of Synthetic Cannabinoid Medications for the Treatment of Pain
Anca Maglaviceanu, Miki Peer, Jason S. Rockel, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 597-612
Closed Access
Identification and pharmacological properties of 2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-INACA), N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-indazole-3-carboxamide (ADB-INACA), and N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazole-3-carboxamide (ADB-HINACA)
Fangqi Cao, Shuchen Yu, Xiujuan Chen, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 255, pp. 116566-116566
Closed Access
Page 1 - Next Page

Scroll to top